[1] Xie XJ, Ye YF, Zhou L,et al. Th17 promotes acute rejection following liver transplantation in rats. J Zhejiang Univ Sci B. 2010;11(11):819-827.
[2] Casas-Melley AT, Falkenstein KP, Flynn LM,et al. Improvement in renal function and rejection control in pediatric liver transplant recipients with the introduction of sirolimus. Pediatr Transplant. 2004;8(4):362-366.
[3] Mas VR, Fisher RA, Maluf DG,et al. Polymorphisms in cytokines and growth factor genes and their association with acute rejection and recurrence of hepatitis C virus disease in liver transplantation.Clin Genet. 2004;65(3): 191-201.
[4] Cueto-Manzano AM, Morales-Buenrostro LE, González-Espinoza L,et al. Markers of inflammation before and after renal transplantation.Transplantation. 2005;80(1): 47-51.
[5] Boniface K, Lecron JC, Bernard FX,et al. Keratinocytes as targets for interleukin-10-related cytokines: a putative role in the pathogenesis of psoriasis.Eur Cytokine Netw. 2005;16(4): 309-319.
[6] Murano M, Maemura K, Hirata I,et al. Therapeutic effect of intracolonically administered nuclear factor kappa B (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis. Clin Exp Immunol. 2000; 120(1):51-58.
[7] 冉江华,张升宁,刘静,等.恒河猴同种异体原位肝移模型的改进[J].中国普外基础与临床杂志,2010,17(7):694-698.
[8] 冉江华,李铸,刘静,等.二袖套法建立恒河猴原位肝移植的稳定模型[J].中国组织工程研究与临床康复,2011,15(5):762-768.
[9] Busuttil RW, Lake JR. Role of tacrolimus in the evolution of liver transplantation. Transplantation. 2004;77(9 Suppl): S44-51.
[10] Solez K. History of the Banff classification of allograft pathology as it approaches its 20th year.Curr Opin Organ Transplant. 2010;15(1):49-51.
[11] Racusen LC, Halloran PF, Solez K. Banff 2003 meeting report: new diagnostic insights and standards.Am J Transplant. 2004; 4(10):1562-1566.
[12] Girnita DM, Burckart G, Zeevi A. Effect of cytokine and pharmacogenomic genetic polymorphisms in transplantation. Curr Opin Immunol. 2008;20(5):614-625.
[13] Cordero-Pérez P, Torres-González L, Muñoz-Espinosa LE. Cytokines expression in peripheral blood cells of patients with orthotopic liver transplant: preliminary results. Rev Gastroenterol Mex. 2011;76(2):108-112.
[14] Yao J, Feng XW, Yu XB,et al. Recipient IL-6-572C/G genotype is associated with reduced incidence of acute rejection following liver transplantation.J Int Med Res. 2013; 41(2):356-364.
[15] Ravaglia G, Forti P, Maioli F, et al. Associations of the -174 G/C interleukin-6 gene promoter polymorphism with serum interleukin 6 and mortality in the elderly.Biogerontology. 2005;6(6):415-423.
[16] Tono T, Monden M, Yoshizaki K,et al. Biliary interleukin 6 levels as indicators of hepatic allograft rejection in rats. Transplantation. 1992;53(6):1195-1201.
[17] Kita Y, Iwaki Y, Demetris AJ,et al. Evaluation of sequential serum interleukin-6 levels in liver allograft recipients. Transplantation. 1994;57(7):1037-1041.
[18] Kunz D, Pross M, König W,et al. Diagnostic relevance of procalcitonin, IL-6 and cellular immune status in the early phase after liver transplantation.Transplant Proc. 1998;30(5): 2398-2399.
[19] Boros P, Suehiro T, Curtiss S,et al. Differential contribution of graft and recipient to perioperative TNF-alpha, IL-1 beta, IL-6 and IL-8 levels and correlation with early graft function in clinical liver transplantation.Clin Transplant. 1997;11(6): 588-592.
[20] Afzali B, Lombardi G, Lechler RI,et al. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease.Clin Exp Immunol. 2007;148(1):32-46.
[21] Függer R, Hamilton G, Steininger R,et al. Intraoperative estimation of endotoxin, TNF alpha, and IL-6 in orthotopic liver transplantation and their relation to rejection and postoperative infection.Transplantation. 1991;52(2): 302-306.
[22] Ohzato H, Yoshizaki K, Nishimoto N,et al. Interleukin-6 as a new indicator of inflammatory status: detection of serum levels of interleukin-6 and C-reactive protein after surgery. Surgery. 1992;111(2):201-209.
[23] Tilg H, Nordberg J, Vogel W,et al.Circulating serum levels of interleukin 6 and C-reactive protein after liver transplantation. Transplantation. 1992;54(1):142-146.
[24] Debonera F, Aldeguer X, Shen X,et al. Activation of interleukin-6/STAT3 and liver regeneration following transplantation.J Surg Res. 2001;96(2):289-295.
[25] Kutukculer N, Clark K, Rigg KM,et al. The value of posttransplant monitoring of interleukin (IL)-2, IL-3, IL-4, IL-6, IL-8, and soluble CD23 in the plasma of renal allograft recipients.Transplantation. 1995;59(3):333-340.
[26] Gorczynski RM, Adams RB, Levy GA,et al. Correlation of peripheral blood lymphocyte and intragraft cytokine mRNA expression with rejection in orthotopic liver transplantation.Surgery. 1996;120(3):496-502.
[27] Takai Y, Wong GG, Clark SC,et al. B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes.J Immunol. 1988;140(2):508-512.
[28] Brouckaert P, Spriggs DR, Demetri G,et al. Circulating interleukin 6 during a continuous infusion of tumor necrosis factor and interferon gamma. J Exp Med. 1989;169(6):2257- 2262.
[29] Cho KA, Lim GW, Joo SY, et al. Transplantation of bone marrow cells reduces CCl4 -induced liver fibrosis in mice. Liver Int. 2011;31(7):932-939.
[30] Ren X, Hogaboam C, Carpenter A,et al. Stem cell factor restores hepatocyte proliferation in IL-6 knockout mice following 70% hepatectomy.J Clin Invest. 2003;112(9):1407- 1418. |